Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer - Results from a phase I trial

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 4, 1997, Pages 691-696

  Hoffmann, Wolfgang ^b   Belka, Claus ^c   Schmidberger, Heinz ^c   Budach, Wilfried ^c   Bochtler, Hans ^a   Hess, Clemens F ^c   Bamberg, Michael ^c  

^a Bristol Meyers Squibb   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c NONE

Author keywords

Combined modality therapy; Concomitant chemoradiotherapy; Head and neck cancer; Paclitaxel

Indexed keywords

CIMETIDINE; CLEMASTINE; DEXAMETHASONE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION INJURY;

ADULT; AGED; AGRANULOCYTOSIS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; PACLITAXEL; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; STOMATITIS;

EID: 0030742933     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00116-8     Document Type: Article

References (34)

1. Adelstein, D. J.; Sharan, V. M.; Earle, A. S.; Shah, A. C.; Vlastou, C.; Haria, C. D.; Damm, C.; Carter, S. G.; Hines, J. D. Simultaneous vs. sequential combined technique therapy for squamous cell head and neck cancer. Cancer 65:1685-1691; 1990.
2. Aisner, J.; Jacobs, M.; Sinabaldi, V.; Gray, W.; Eisenberger, M. Chemoradiotherapy for the treatment of regionally advanced head and neck cancers. Semin. Oncol. 21(Suppl. 12):3544; 1994.
3. Aisner, J.; Belani, C. P.; Kearns, C.; Conley, B.; Hiponia, D.; Engstrom, C.; Zuhowski, E.; Egorin, M. J. Feasibility and pharmacokinetics of PAC, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non small cell lung cancer. Semin. Oncol. 22(Suppl. 12):1721; 1995.
4. Ajani, J. A.; Ilson, D. H.; Daugherty, K.; Kelsen, D. P. Paclitaxel in the treatment of carcinoma of the esophagus. Semin. Oncol. 22(Suppl. 6):3540; 1995.
5. Allen, J. N.; Moore, S. A.; Wewers, M. D. Taxol enhances but does not induce interleukin1 beta and tumor necrosis factor alpha production. J. Lab. Clin. Med. 122:374-381; 1993.
6. Allen, M. E.; Vandenburg, M. J. Good clinical practice: rules, regulations and their impact on the investigator. Br. J. Clin. Pharmacol. 33:463-451; 1992.
7. AlSarraf, M.; Pajak, T. F.; Marcial, V. A.; Mowry, P.; Cooper, J. S.; Stetz, J.; Ensley, J. F.; Velez-Garcia, E. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study. Cancer 59:259-265; 1987.
8. Arbruck, S. A.; Blaylock, B. A. Dose and schedule issues. In: McGuire, W. P.; Rowinsky, E. K., eds. Paclitaxel in cancer treatment. New York: Marcel Dekker; 1995:81-89.
9. Chang, A. Y.; Kim, K.; Glick, J.; Anderson, T.; Karp, D.; Johnson, D. Phase II study of taxol, merbarone, and piroxantrone in stage IV nonsmall-cell lung cancer: The Eastern Cooperative Oncology Group Results. J. Natl. Cancer Inst. 85:388-394; 1993.
10. Choy, H.; Akerley, W.; Safran, H.; Clark, J.; Rege, V.; Papa, A.; Glantz, M.; Puthawala, Y.; Soderberg, C.; Leone, L. Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced nonsmall-cell lung cancer. J. Clin. Oncol. 12:2682-2686; 1994.
11. Forastiere, A. A. Use of paclitaxel (Taxol) in squamous cell carcinoma of the head and neck. Semin. Oncol. 20(Suppl. 3):56-60; 1993.
12. Forastiere, A. A.; Neuberg, D.; Taylor, S. G. Phase-II evaluation of taxol in advanced head and cancer: An Eastern Cooperativ oncology Group trial. Proc. Am. Soc. Clin. Oncol. 12:277, 1993.
13. Forastiere, A. A.; Flood, W. A.; Koch, W.; Eisele, D.; Lee, D. J. Phase I Study of Paclitaxel administered over 96 h and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck. Proc. Am. Soc. Clin. Oncol. 15:884; 1996.
14. Gerad, C. R.; Jones, J. M. Radiation and Paclitaxel effects on synchronized human cervical carcinoma cells. Int. J. Radiat. Oncol. Biol. Phys. 29:565-569; 1994.
15. Holms, F. A.; Walters, R. S.; Thierault, R. L. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J. Natl. Cancer Inst. 83:1797-1805; 1991.
16. ICRU Report 50: Prescribing,recording and reporting photon beam therapy, International Comission on Radiation Units and Measurements. Bethesda, MD; 1993.
17. Jacobs, C. M.; Lyman, G.; Velez-Garcia, E.; Sridhar, K. S.; Knight, W.; Hochster, H.; Goodnough, L. T.; Mortimer, J. E.; Einhorn, L. H.; Schacter, L. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J. Clin. Oncol. 10:257-263; 1992.
18. Leonard, C. E.; Chan, D. C.; Chou, T.-C.; Kumar, R.; Bunn, P. A. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck. Cancer Res. 56:5198-5204; 1996.
19. Liebmann, J. E.; Cock, J. A.; Fisher, J. Changes of survival curve parameters in human tumour and rodent cells exposed to paclitaxel (taxol). Int. J. Radiat. Oncol. Biol. Phys. 29:559-564; 1994.
20. Mason, K. A.; Milas, L.; Peters, L. J. Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa. Int. J. Radiat. Oncol. Biol. Phys. 32:1381-1389; 1995.
21. McGuire, W. P.; Rowinsky, E. K.; Rosenhein, N. B. Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann. Intern. Med. 111:273-279; 1989.
22. Merlano, M.; Corvo, R.; Margarino, G.; Benasso, M.; Rosso, R.; Sertoli, M. R.; Cavallari, M.; Scala, M.; Guenzi, M.; Siragusa, A.; et al. Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial. Cancer 67:915-921; 1991.
23. Milas, L.; Hunter, N. R.; Mason, K. A.; Milross, C. G.; Saito, Y.; Peters, L. J. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res. 55:3564-3568; 1995.
24. Murphy, W. K.; Fossella, F. V.; Winn, R. J.; Shin, D. M.; Hynes, H. E.; Gross, H. M.; Davilla, E.; Leimert, J.; Dhingra, H.; Raber, M. N. Phase II study of Taxol in patients with untreated advanced non small cell lung cancer. J. Natl. Cancer Inst. 85:384-388; 1993.
25. Schiff, P. B.; Fant, J.; Horwitz, S. B. Promotion of microtubuli assembly in vitro by taxol. Nature 277:665-667; 1979.
26. Schiff, P. B.; Horowitz, S. B. Taxol stabilizes microtubles in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 77:1561-1565; 1980.
27. Schiff, P. B.; Gubit, R.; Kashimawo, S. Interaction with ionizing radiation. In: McGuire, W. P.; Rowinsky, E. K., eds. Paclitaxel in cancer treatment. New York: Marcel Dekker; 1995:81-89.
28. Smid, L.; Lesnicar, H.; Zakotnik, B.; Soba, E.; Budihna, M.; Furlan, L.; Zargi, M.; Rudolf, Z. Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer - Preliminary report. Int. J. Radiat. Oncol. Biol. Phys. 32:769-775; 1995.
29. Stell, P. M. Adjuvant chemotherapy in head and neck cancer. Semin. Radiat. Oncol. 2:195-205; 1992.
30. Steren, A.; Sevin, B.; Perras, J.; Ramos, R.; Angioli, R.; Nguyen, H.; Koechli, O.; Averette, H. E. Taxol as a radiation sensitizer: A flow cytometric study. Gynecol. Oncol. 50:89-93; 1993.
31. Steren, A.; Sevin, B. U.; Perras, J. Paclitaxel sensitizes human ovarian cancer cells to radiation. Cancer Res. 48:252-258; 1993.
32. Vokes, E. E.; Stupp, R.; Haraf, D. Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil and concomitant radiotherapy for poor prognosis head and neck cancer. Semin. Oncol. 22:47-52; 1995.
33. Vokes, E. E.; Weichselbaum, R. R.; Mick, R.; McEvilly, J. M.; Haraf, D. J.; Panje, W. R. Favorable longterm survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J. Natl. Cancer Inst. 84:877-882; 1992.
34. Vokes, E. E.; Haraf, D. J.; Stenson, K.; Stupp, R.; Malone, D.; Levin, J.; Weichselbaum, R. R. The role of paclitaxel in the treatment of head and neck cancer. Semin. Oncol. 5(Suppl 12):8-12; 1995.